|
3008
|
AOH1160
|
First-in-class, potent and orally available PCNA inhibitor |
€120.00 |
|
3144
|
Blebbistatin, (+)-
|
Negative control of (±)-Blebbistatin as an inhibitor of class II myosins |
€90.00 |
|
3074
|
Blebbistatin, (-)-
|
Selective inhibitor of class II myosins; Active enantiomer of (±)-Blebbistatin |
€90.00 |
|
3104
|
Candesartan cilexetil
|
Potent and highly specific AT2 receptor antagonist |
€50.00 |
|
3089
|
CX516
|
Positive allosteric modulator of AMPA receptor |
€70.00 |
|
3090
|
CX546
|
Positive allosteric modulator of AMPA receptor |
€95.00 |
|
2987
|
DFP00173
|
Potent and selective AQP3 inhibitor |
€140.00 |
|
3020
|
DS44960156
|
Selective MTHFD2 inhibitor |
€160.00 |
|
3102
|
Losartan
|
Non-peptide, potent and orally active angiotensin II receptor antagonist |
€60.00 |
|
3109
|
ML-792
|
Potent and selective inhibitor of SUMO-activating enzyme (SAE) |
€145.00 |
|
2603
|
Nitrosocyclohexyl acetate, 1-
|
HNO donor |
€150.00 |
|
3101
|
Palonosetron hydrochloride
|
Highly potent, selective and orally active 5-HT3 antagonist |
€150.00 |
|
3061
|
RBPJ inhibitor RIN1
|
First-in-class, potent and selective RBPJ inhibitor |
€145.00 |
|
3110
|
Remdesivir
|
Potent and selective inhibitor of Ebola virus (EBOV); Broad-spectrum antiviral agent |
€90.00 |